Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
47
天
First-in-human anti-Trop2 CAR-T cell therapy in refractory INI-1/BRM-deficient sinonasal carcinoma: A case report
作者
Guangfei Li; Yuting Lai; Liang Wang; Hongjia Zhu; Min Chen; Jifang Wang; Taomin Huang; Liqing Kang; Nan Xu; Minghao Li; Xiaoyan Lou; Zhou Yu; Wei Wang; Minghao Fan; Jiali Wu; Haitao Wu; Lei Yu; Peijie He; Hongmeng Yu; Jian Chen展开收起
作者单位
ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China; School of Pharmacy, East China Normal University, Shanghai 200062, China; Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai 200000, China; Department of Nursing, Eye & ENT Hospital, Fudan University, Shanghai 200031, China; Department of Pharmacy, Eye & ENT Hospital, Fudan University, Shanghai 200031, China; Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai 200031, China展开收起
159
天
ICAM-1 as a biomarker of efficacy for oncolytic coxsackievirus A21 in patient-derived Ewing sarcoma models
作者
Richard T. Baugh; Tyler Barr; Elizabeth A. Roundhill; Fay Ismail; Milene Volpato; Graham P. Cook; Susan A. Burchill; Fiona Errington-Mais展开收起
作者单位
Leeds Institute of Medical Research, University of Leeds, St James’s University Hospital, Wellcome Trust Brenner Building, Beckett Street, Leeds LS9 7TF, UK展开收起
113
天
Phase 1 evaluation of APN401, an autologous CBL-B-silenced PBMC therapy, in advanced solid tumors
作者
Alexander Dohnal; Nina Worel; Thomas Bogenrieder; Thorsten Fuereder; Martin Burian; Dominik Wolf; Gerald Prager; Richard Greil; Anja Peterbauer-Scherb; Beate Schrenk; Stefan Bunka; Ernesto Abila; Felix Batrina; Maria Urban; Julia Buchberger; Alice Schwarzboeck; Bernhard Peball; Sandra Seidl; Hannes Muehleisen; Stefan Stranner; Mario Kuttke; Angela Halfmann; Sarah Bischof; Andreas Birbach; Romana Gugenberger展开收起
作者单位
InvIOs GmbH, Campus Vienna Biocenter 5, 1030 Vienna, Austria; Medical University of Vienna, Department of Transfusion Medicine and Cell Therapy, Waehringer Guertel 18-20, 1090 Vienna, Austria; Medical University of Vienna, Department of Medicine I, Division of Oncology, Waehringer Guertel 18-20, 1090 Vienna, Austria; Ordensklinikum Linz GmbH, Barmherzige Schwestern, Seilerstaette 4, 4020 Linz, Austria; Medical University Innsbruck, Department of Internal Medicine V, Hematology and Oncology, Anichstrasse 35, 6020 Innsbruck, Austria; Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria; Austrian Red Cross, Blood Transfusion Service for Upper Austria, Krankenhaustrasse 7, 4010 Linz, Austria展开收起
373
天
A novel spliceosome inhibitor triggers anti-tumor CD4+ and CD8+ T cell responses in murine models of pediatric-relevant cancer
作者
Mélanie Demeules; Boris Letribot; Lisa Giraldo; Congcong Li; Alexandre Maucuer; Birgit Geoerger; Mouad Alami; Sébastien Apcher展开收起
作者单位
Université Paris-Saclay, INSERM UMR1015, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Université Paris-Saclay, Gustave Roussy, INSERM UMR1363, Biothérapies Innovantes, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Université Paris Cité, INSERM U1342, Institut de Recherche Saint-Louis (IRSL), Paris, France; Université Paris-Saclay, CNRS, BioCIS, 91400 Orsay, France; SABNP, Université Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94800 Villejuif, France展开收起
275
天
Interleukin-21 expressing oncolytic vaccinia virus elicits systemic anti-tumor immune response and synergizes with immunotherapies
作者
Rong Zhang; Tingting Wang; Yu Wang; Chenggang Hong; Yun Qin; Kangchen Ye; Hu Zhao; Fang Hu; Jinlu Cai; Jin Fu展开收起
作者单位
Hangzhou Converd Co. Ltd., Hangzhou, China; Department of General Surgery, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China展开收起
109
天
USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells
作者
Ayokunnumi Ogunsanya; Fatimah Alfaran; Omuya Noel Amadu; Achuth Padmanabhan展开收起
作者单位
Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA展开收起
FAQ
Molecular Therapy Oncology审稿要多久?
截至2026-11-13,CrushSCI 收录了 Molecular Therapy Oncology 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 47 天(First-in-human anti-Trop2 CAR-T cell therapy in refractory INI-1/BRM-deficient sinonasal carcinoma: A case report,2026-08-27 收稿,2026-10-13 录用),最慢一篇用了 490 天;平均 187.2 天,中位数 159 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
